Articles

Page 78 of 79

Molecular characterization of virus-induced autoantibody responses

Authors: P Krebs, B Ludewig, Metters, Ö Türeci and U Sahin

Citation: Cancer Cell International 2004 4(Suppl 1):S59

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Immunization of Rhesus monkeys with a conjugate vaccine IGN402 induces immune responses against carbohydrate and protein antigens, and cancer cells

Authors: G Waxenecker, R Kircheis, P Vondru, I Zinöcker, D Häring, D Krey, A Nechansky, GC Mudde, G Himmler and H Loibner

Citation: Cancer Cell International 2004 4(Suppl 1):S57

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
The receptor for hyaluronic acid mediated motility (RHAMM/CD168) is a leukemia associated antigen eliciting both humoral and cellular immune responses in patients with acute myeloid leukemia (AML)

Authors: J Greiner, M Ringhoffer, L Li, T Barth, T Wölfel, H Döhner and M Schmitt

Citation: Cancer Cell International 2004 4(Suppl 1):S55

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Preclinical investigation of DNA immunization with a rearranged human papillomavirus type 16 (HPV16) E7 oncogene

Authors: P Öhlschläger, M Pes, W Osen, M Dürst, A Schneider, L Gissmann and AM Kaufmann

Citation: Cancer Cell International 2004 4(Suppl 1):S53

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
New TRP-2-derived T helper epitopes identified in HLA-DRB1*0301 transgenic mice elicit spontaneous T cell responses in HLA-DRB1*03 and HLA-DRB1*04 melanoma patients

Authors: M Song, W Osen, D Thomas, N Daniel, XD Nguyen, J Mueller-Berghaus, H Kropshofer, D Schadendorf and A Paschen

Citation: Cancer Cell International 2004 4(Suppl 1):S51

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines

Authors: MS von Bergwelt-Baildon, B Maecker, F Fiore, LM Nadler and JL Schultze

Citation: Cancer Cell International 2004 4(Suppl 1):S49

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Addition of histamine to IL-2 treatment augments T1 cell-function in melanoma patients in vivo: results from a randomized clinical trial of IL-2 with or without histamine (MP 104)

Authors: AM Asemissen, C Scheibenbogen, A Letsch, K Hellstrand, K Gehlsen, E Thiel and U Keilholz

Citation: Cancer Cell International 2004 4(Suppl 1):S47

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Survival and homing of ex vivo expanded donor derived dendritic cells after allogeneic BMT

Authors: C Schimmelpfennig, S Schulz, C Arber, J Baker, I Tarner, J McBride, CG Fathman, C Contag and R Negrin

Citation: Cancer Cell International 2004 4(Suppl 1):S45

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Phase I/II study of vaccination with immature and mature dendritic cells in patients with melanoma and renal cell carcinoma

Authors: M Petrini, L Fiammenghi, L Ridolfi, M Stefanelli, G Migliori, C Brolli, A Riccobon and R Ridolfi

Citation: Cancer Cell International 2004 4(Suppl 1):S44

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Optimizing the antigen loading of dendritic cells with exogenous peptides

Authors: ES Schultz, D Dieckmann, B Ring and G Schuler

Citation: Cancer Cell International 2004 4(Suppl 1):S43

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Parvovirus H1-induced tumor cell death enhances human immune response via crosspresentation of dendritic cells

Authors: M Zeidler, J Cornelis, T Woelfel, J Rommeleare, PR Galle, M Heike and M Moehler

Citation: Cancer Cell International 2004 4(Suppl 1):S42

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Efficient in vitro expression of human reverse transcriptase (hTERT) in dendritic cells of lung cancer patients using RNA electrotransfection

Authors: A-K Brill, W Klapper, U Weingartz, I Bolz, A Heiser, D Kabelitz, M Kneba and B Gahn

Citation: Cancer Cell International 2004 4(Suppl 1):S41

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
The European Searchable Tumour Cell and Databank, ESTDAB, as a tool for research in cancer immunology

Authors: L Müller, D Schadendorf, S Stevanovic, A Knights, E Badalian, L Wedel and G Pawelec

Citation: Cancer Cell International 2004 4(Suppl 1):S40

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Dendritic cell-based immunotherapy of hormone refractory prostate carcinoma (HRPCa) – a pilot trial

Authors: B Hildenbrand, A Langenkamp, B Sauer, C Stoll, O Constantiniu, R Leo, C Unger and M Azemar

Citation: Cancer Cell International 2004 4(Suppl 1):S39

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Development, monitoring and first immunological results of a phase I/II vaccination trial using genetically modified allogeneic breast cancer cells

Authors: B Gückel, S Stumm, C Rentzsch, S Kayser, I Gruber, A Marmé, J Huober, F Autschbach, S Meuer and D Wallwiener

Citation: Cancer Cell International 2004 4(Suppl 1):S38

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Particulate antigenic structures: highly immunogenic carriers for T cell epitopes derived from tumour antigens

Authors: M Brinkman, J Walter, S Grein, MJW Thies, C Reiser and J Hess

Citation: Cancer Cell International 2004 4(Suppl 1):S37

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Chimeric carrier proteins for targeted delivery of tumor antigens to professional antigen presenting cells

Authors: F Rohrbach, R Weth, M Kursar, H-W Mittrücker and W Wels

Citation: Cancer Cell International 2004 4(Suppl 1):S36

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Identification of a melanoma-associated chondroitin sulfate proteoglycan (MCSP) peptide recognized by CD4⁺ T lymphocytes on human melanoma cells

Authors: CS Erfurt, C Heirman, K Thielemans, G Schuler and ES Schultz

Citation: Cancer Cell International 2004 4(Suppl 1):S35

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Induction of leukemia reactive, allogeneic donor lymphocytes

Authors: AK Kaskel, T Portugal, H Veelken and J Finke

Citation: Cancer Cell International 2004 4(Suppl 1):S34

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Tumor-specific murine T cell receptors displace endogenous TCRs in human T cells

Authors: R-H Voss, S Thomas, J Kuball, R Engel, M Brkic, P Guillaume, P Romero, C Huber and M Theobald

Citation: Cancer Cell International 2004 4(Suppl 1):S33

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
The kinetics of accumulation of adoptively transferred ovalbumin-specific T cells in a transgenic, ovalbumin-expressing murine tumor

Authors: R Agger, MS Petersen, CC Fleischer and ME Hokland

Citation: Cancer Cell International 2004 4(Suppl 1):S32

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Isolated γδ T cells express natural cytotoxicity receptors

Authors: M von Lilienfeld-Toal, J Nattermann, G Feldmann and IGH Schmidt-Wolf

Citation: Cancer Cell International 2004 4(Suppl 1):S31

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Enrichment of functional CD8 memory T cells specific for MUC1 in Bone Marrow of Multiple Myeloma Patients

Authors: M Witzens, C Choi, M Bucur, M Feuerer, N Sommerfeldt, A Trojan, A Ho, V Schirrmacher, H Goldschmidt and P Beckhove

Citation: Cancer Cell International 2004 4(Suppl 1):S30

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
NFκB activation and TGFβ loss signatures are prominent ex vivo responses of peripheral blood mononuclear cells

Authors: T Zander, D Re, S Beyer, M Hellmich, A Popov, I Büchmann, J Wolf, S Debey and JL Schultze

Citation: Cancer Cell International 2004 4(Suppl 1):S29

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Modulation of tumour directed B cell responses by NK cells

Authors: M Jensen, A Buhl, C Hoyer, S Schmitz, S Tawadros, H Harald-Sedlacek, J Schultze and F Berthold

Citation: Cancer Cell International 2004 4(Suppl 1):S28

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Regulation of p53 tumor specific immune responses in colorectal cancer patients

Authors: M Büter, M Gasser, T Mueller, D Meyer, N Schramm, A Müller, A Trumpfheller, S Müller, A Thiede and AM Waaga-Gasser

Citation: Cancer Cell International 2004 4(Suppl 1):S26

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Release of iC3b from apoptotic pancreatic tumor cells induces tolerance by binding to immature dendritic cells

Authors: J Schmidt, MW Büchler and A Märten

Citation: Cancer Cell International 2004 4(Suppl 1):S24

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Increased effector functions of a monoclonal antibody by glycoform engineering

Authors: G Waxenecker, M Schuster, P Umana, P Brünker, I Froihofer, S Wiederkum, C Schwager, H Klug, GC Mudde, G Himmler and H Loibner

Citation: Cancer Cell International 2004 4(Suppl 1):S22

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Limiting the risk of immunogenicity by identification and removal of T-cell epitopes (DeImmunisation™)

Authors: K Hellendoorn, T Jones, J Watkins, M Baker, A Hamilton and F Carr

Citation: Cancer Cell International 2004 4(Suppl 1):S20

Content type: Poster presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers

Authors: A Bender, J Karbach, A Neumann, M Biskamp, D Jäger, S Gnjatic, E Hoffman, LJ Old, A Knuth and E Jäger

Citation: Cancer Cell International 2004 4(Suppl 1):S18

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Transitory response to vaccination with PSCA-/PSA-peptide loaded, autologous dendritic cells in patients with metastatic, hormone-refractory prostate cancer

Authors: AK Kaskel, R Zeiser, R Jochim, W Schultze-Seemann, CF Waller and H Veelken

Citation: Cancer Cell International 2004 4(Suppl 1):S16

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
The role of glycosylation as a modulator for signalling strength in T cells

Authors: B Hauptrock, J Kuball, R-H Voss, M Brkic, C Huber and M Theobald

Citation: Cancer Cell International 2004 4(Suppl 1):S14

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Reversible HLA multimers (streptamers) for isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens

Authors: J Neudorfer, B Schmidt, K Huster, M Schiemann, T Schmidt, H Wagner, C Peschel, DH Busch and H Bernhard

Citation: Cancer Cell International 2004 4(Suppl 1):S12

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Adoptive T cell therapy using antigen-specific CD8⁺ T cells for the treatment of patients with metastatic melanoma: a phase I clinical study

Authors: N Meidenbauer, S Vogl, M Laumer, J Heymann, R Andreesen and A Mackensen

Citation: Cancer Cell International 2004 4(Suppl 1):S10

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Rapid functional exhaustion and deletion of cytotoxic T lymphocytes following immunization with recombinant adenovirus

Authors: E Scandella, P Krebs, B Odermatt and B Ludewig

Citation: Cancer Cell International 2004 4(Suppl 1):S8

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Genetically modified natural killer cells specifically recognizing the tumor-associated antigens ErbB2/HER2 and EpCAM

Authors: C Uherek, T Müller, T Tonn, B Uherek, H-G Klingemann and WS Wels

Citation: Cancer Cell International 2004 4(Suppl 1):S7

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
MMP-7 inhibits CTL – tumor cell interaction

Authors: S Gregor, V Alla, J Kuball, M Theobald, PR Galle, D Strand and S Strand

Citation: Cancer Cell International 2004 4(Suppl 1):S6

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Increased frequency of CTLA4⁺ TGFβ⁺ CD4⁺ CD25⁺ T cells in peripheral blood of patients with chronic lymphatic leukemia and multiple myeloma

Authors: M Beyer, M Kochanek, M von Bergwelt-Baildon, A Popov, J Wolf and JL Schultze

Citation: Cancer Cell International 2004 4(Suppl 1):S5

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
HLA DR-directed bispecific single-chain Fv antibodies for lymphoma therapy

Authors: Y Wachter, J Brünke, S Schuster, K Barbin, M Peipp, T Valerius, M Gramatzki, G Fey and R Repp

Citation: Cancer Cell International 2004 4(Suppl 1):S4

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Tolerability and efficacy of the trifunctional antibody removab^® (anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study

Authors: P Wimberger, A Burges, V Gorbounova, H Sommer, B Schmalfeldt, J Pfisterer, M Lichinitser, A Makhson, M Ströhlein, W Eiermann, M Biakhov, V Moiseenko, A du Bois and R Kimmig

Citation: Cancer Cell International 2004 4(Suppl 1):S3

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Antibody-based immunoreceptors: the impact of signalling domain, binding affinity and costimulation

Authors: A Hombach, C Heuser and H Abken

Citation: Cancer Cell International 2004 4(Suppl 1):S2

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Bispecific costimulatory molecules for activation of tumor-killing lymphocytes

Authors: R Weth, M Biburger and W Wels

Citation: Cancer Cell International 2004 4(Suppl 1):S1

Content type: Oral presentation Published on: 1 July 2004

This article is part of a Supplement: Volume 4 Supplement 1
- View Full Text
- View PDF
Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients

Malignant peripheral nerve sheath tumors (MPNSTs) are neoplasms leading to death in most cases. Patients with Neurofibromatosis type 1 have an increased risk of developing this malignancy. The metabolites of t...

Authors: Silke Frahm, Andreas Kurtz, Lan Kluwe, Faris Farassati, Reinhard E Friedrich and Victor F Mautner

Citation: Cancer Cell International 2004 4:4

Content type: Primary research Published on: 17 May 2004
- View Full Text
- View PDF
Chemosensitivity assay in mice prostate tumor: Preliminary report of flow cytometry, DNA fragmentation, ion ratiometric methods of anti-neoplastic drug monitoring

Flow cytometry, DNA fragmentation, ion ratiomateric analysis and NMR peaks characterized drug chemosensitivity of antineoplastic drugs. Hypotheses were: 1. The chemosensitive effect of different cancer cell li...

Authors: Rakesh Sharma and Richard Kline

Citation: Cancer Cell International 2004 4:3

Content type: Primary research Published on: 19 March 2004
- View Full Text
- View PDF
Phospholipse c inhibitor, u73122, stimulates release of hsp-70 stress protein from A431 human carcinoma cells

Accumulating evidences suggest that Hsp 70, the inducible component of Hsp70 family, might release from a living cell. Here we show that a pharmacological inhibitor of phospholipase C activity U73122 caused a ...

Authors: Anton L Evdonin, Irina V Guzhova, Boris A Margulis and Natalia D Medvedeva

Citation: Cancer Cell International 2004 4:2

Content type: Primary research Published on: 27 February 2004
- View Full Text
- View PDF
Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma

The aim of this work was to investigate in vitro the putative role of EGR-1 in the growth of glioma cells. EGR-1 expression was examined during the early passages in vitro of 17 primary cell lines grown from 3...

Authors: Antonella Calogero, Vincenza Lombari, Giorgia De Gregorio, Antonio Porcellini, Severine Ucci, Antonietta Arcella, Riccardo Caruso, Franco Maria Gagliardi, Alberto Gulino, Gaetano Lanzetta, Luigi Frati, Dan Mercola and Giuseppe Ragona

Citation: Cancer Cell International 2004 4:1

Content type: Primary research Published on: 7 January 2004
- View Full Text
- View PDF
Tumor suppressor gene E-cadherin and its role in normal and malignant cells

E-cadherin tumor suppressor genes are particularly active area of research in development and tumorigenesis. The calcium-dependent interactions among E-cadherin molecules are critical for the formation and mai...

Authors: Nives Pećina-Šlaus

Citation: Cancer Cell International 2003 3:17

Content type: Review Published on: 14 October 2003
- View Full Text
- View PDF
Styrylpyrone Derivative (SPD) induces apoptosis in a caspase-7-dependent manner in the human breast cancer cell line MCF-7

Styrylpyrone derivative (SPD) is a plant-derived pharmacologically active compound extracted from Goniothalamus sp. Previously, we have reported that SPD inhibited the proliferation of MCF-7 human breast cancer c...

Authors: Alvin Teck Chien Lee, Hawariah Lope Pihie Azimahtol and Ann Na Tan

Citation: Cancer Cell International 2003 3:16

Content type: Primary research Published on: 4 October 2003
- View Full Text
- View PDF
A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis

The CCN (C YR61 [Cystein-rich61]/C TGF [connective tissue growth factor]/N OV [Nephroblastoma overexpressed]) proteins constitute a family of regulatory factors involved in many aspects of cell proliferation and ...

Authors: Nathalie Planque and Bernard Perbal

Citation: Cancer Cell International 2003 3:15

Content type: Review Published on: 22 August 2003
- View Full Text
- View PDF
Human mast cells decrease SLPI levels in type II – like alveolar cell model, in vitro

Mast cells are known to accumulate at sites of inflammation and upon activation to release their granule content, e.g. histamine, cytokines and proteases. The secretory leukocyte protease inhibitor (SLPI) is p...

Authors: Camilla Hollander, Max Nyström, Sabina Janciauskiene and Ulla Westin

Citation: Cancer Cell International 2003 3:14

Content type: Primary research Published on: 20 August 2003
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Follow

Annual Journal Metrics

On the blog

Institutional membership

Funding your APC

​​​​​​​​​

Cancer Cell International

Contact us